There are contraindications! Be sure to consult your doctor before taking any medication!

Grifotriaxona

Grifotriaxona - A broad-spectrum cephalosporin antibiotic with a very long half-life and high penetrability to meninges, eyes and inner ears.

Indication: For the treatment of the infections (respiratory, skin, soft tissue, UTI, ENT) caused by S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staph

Grifotriaxona is a cephalosporin/cephamycin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. Grifotriaxona has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of Grifotriaxona results from the inhibition of cell wall synthesis and is mediated through Grifotriaxona binding to penicillin binding proteins (PBPs). Grifotriaxona is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases.

Pharmaceutical active ingredients containing related brand and generic drugs, medications or other health care products:

• Ceftriaxone Sodium

Grifotriaxona available forms, composition, doses:

• Injectable; Injection; Ceftriaxone Sodium 1 g

Grifotriaxona destination | category:

• Human:
• Cephalosporins third-generation

Indications and usages, anatomical therapeutic chemical and diseases classification codes:

• J01DD04 - Ceftriaxone

Pharmaceutical companies, researchers, developers, manufacturers, distributors and suppliers:

• Chile Laboratorios